For a variety of medical applications, Kromek supplies OEMs with customisable or complete CZT based detection solutions to improve patient outcomes worldwide and ultimately make the world a healthier and safer place.
Further to the Group’s announcement of 6 September 2023, Kromek, is pleased to announce that it has completed the refinancing of its borrowing facility with the signing of a new £5.5m secured term loan (the “New Facility”).